Answers are grounded in this paper and cite their sources.
Our study confirms previously known CLDN gene expression patterns and identifies new ones, which may have applications in the detection, prognosis and therapy of several human cancers. In particular we identify several malignancies that express CLDN3 and CLDN4. These cancers may represent ideal candidates for a novel therapy being developed based on CPE, a toxin that specifically binds claudin-3 and claudin-4.
No takes yet. Share an insight, caveat, or question.
Hewitt et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: